Leah Still Celebrates Two Year’s Cancer Free! “No Matter How Hard, We Never Gave Up”

It’s hard to believe it’s been two years since fans and followers from all over the world celebrated when they found out the young-but-mighty Leah Still was cancer free.

Today, her dad Devon Still, penned this message on social media.

“I want to wish a Happy 2nd Birthday to my daughter, Leah. Today marks 2 years in remission! From the moment we took this picture in the hospital, right before doctors walked in the room and said she had cancer, we had an extremely tough fight. But no matter how hard it got we never gave up. So today, we celebrate your strength and perseverance Leah! I love you more than you could ever possibly know.”

The former Bengals defensive lineman and current Houston Texan is now looking forward to working with NASA to fight cancer through research in space. The NFL dad and husband shared this post on Instagram:

Every day, NASA spacecraft beam down hundreds of petabytes of data, all of which has to be codified, stored and distributed to scientists across the globe. Increasingly, artificial intelligence is helping to “read” this data as well, highlighting similarities between datasets that scientists might miss.

For the past 15 years, the big data techniques pioneered by NASA’s Jet Propulsion Laboratory (JPL) in Pasadena, California, have been revolutionizing biomedical research.

The NCI-supported Early Detection Research Network (EDRN) is a consortium of biomedical investigators who share anonymized data on cancer biomarkers, chemical or genetic signatures related to specific cancers. Their goal is to pool all their research data into a single, searchable network, with the goal of translating their collective work into techniques for early diagnosis of cancer or cancer risk.

In the time they’ve worked together, JPL and EDRN‘s efforts have led to the discovery of six new Food and Drug Administration-approved cancer biomarkers and nine biomarkers approved for use in Clinical Laboratory Improvement Amendments labs. The FDA has approved each of these biomarkers for use in cancer research and diagnosis. These agency-approved biomarkers have been used in more than 1 million patient diagnostic tests worldwide.

This whole program is in partnership with Devon and Leah Still’s Still Strong Foundation that helps other families battling childhood cancers. Devon posted how proud of his daughter he is: